D. Rasmussen

发表

Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations.

S. Yen, B. Ishizuka, M. Quigley, 1983, The Journal of clinical endocrinology and metabolism.

Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels.

A. Matsumoto, C. Wilkinson, S. Yellon, 1999, Endocrinology.

Aging‐dependent changes in the effect of daily melatonin supplementation on rat metabolic and behavioral responses

S. Yellon, D. Rasmussen, D. R. Mitton, 2001, Journal of pineal research.

Melatonin effect on rat body weight regulation in response to high-fat diet at middle age

D. Rasmussen, S. Puchalski, Jill N. Green, 2003, Endocrine.

Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis.

C. Wilkinson, D. Rasmussen, B. M. Boldt, 2000, Alcoholism, clinical and experimental research.

Pituitary responses to synthetic corticotropin-releasing hormone: absence of modulatory effects by estrogen and progestin.

W. Vale, J. Rivier, J. Liu, 1987, American journal of obstetrics and gynecology.

Prazosin reduces alcohol drinking throughout prolonged treatment and blocks the initiation of drinking in rats selectively bred for high alcohol intake.

J. Froehlich, Stephen M. Fischer, D. Rasmussen, 2013, Alcoholism, clinical and experimental research.

alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol.

G. Koob, M. Raskind, B. Walker, 2008, Alcohol.

Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals.

J. Froehlich, D. Rasmussen, C. Kincaid, 2015, Alcoholism, clinical and experimental research.

Role of oxytocin in the modulation of ACTH release in women.

J. Liu, S. Yen, B. Suh, 1986, Neuroendocrinology.

Melatonin effects on metabolism independent of gonad function

D. Rasmussen, S. Puchalski, Jill N. Green, 2003, Endocrine.

Pulsatile beta-endorphin release from the human pituitary in vitro.

J. Liu, S. Yen, W. Rossmanith, 1988, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

New concepts in the regulation of hypothalamic gonadotropin releasing hormone (GnRH) secretion

D. Rasmussen, 1986, Journal of endocrinological investigation.

Daily Melatonin Administration at Middle Age Suppresses Male Rate Visceral Fat, Plasma Leptin, and Plasma Insulin to Youthful Levels.

A. Matsumoto, C. Wilkinson, S. Yellon, 1999, Endocrinology.

Acute alcohol effects on opiomelanocortinergic regulation.

C. Wilkinson, D. Rasmussen, B. M. Boldt, 1998, Alcoholism, clinical and experimental research.

Pulsatile rhythms of adrenocorticotropin (ACTH) and cortisol in women with endogenous depression: evidence for increased ACTH pulse frequency.

J. Gillin, J. Liu, S. Yen, 1987, The Journal of clinical endocrinology and metabolism.

In vitro perifusion of human hypothalamic and pituitary tissue.

D. Rasmussen, 1989, Methods in enzymology.

Intrinsic pulsatility of luteinizing hormone release from the human pituitary in vitro.

J. Liu, S. Yen, M. Gambacciani, 1987, Neuroendocrinology.

EFFECTS OF CHRONIC NICOTINE TREATMENT AND WITHDRAWAL ON HYPOTHALAMIC PROOPIOMELANOCORTIN GENE EXPRESSION AND NEUROENDOCRINE REGULATION

D. Rasmussen, 1998, Psychoneuroendocrinology.

The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis

D. Rasmussen, 1991, Journal of endocrinological investigation.

Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: evidence for a central mechanism.

S. Yen, J. Mortola, D. Rasmussen, 1989, Journal of Clinical Endocrinology and Metabolism.

GnRH release from the mediobasal hypothalamus: in vitro inhibition by corticotropin-releasing factor.

S. Yen, M. Gambacciani, D. Rasmussen, 1986, Neuroendocrinology.

Stress and PTSD Mechanisms as Targets for Pharmacotherapy of Alcohol Abuse, Addiction, and Relapse

D. Rasmussen, 2016 .

Acoustic startle in alcohol-naïve male rats predicts subsequent voluntary alcohol intake and alcohol preference.

D. Rasmussen, C. Kincaid, 2015, Alcohol and alcoholism.

The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats.

M. Raskind, J. Froehlich, D. Rasmussen, 2009, Alcoholism, clinical and experimental research.

GnRH Release from the Mediobasal Hypothalamus

S. Yen, M. Gambacciani, D. Rasmussen, 1986 .

GnRH release from the mediobasal hypothalamus. In vitro regulation by oxytocin.

S. Yen, M. Gambacciani, D. Rasmussen, 1986, Neuroendocrinology.

Synchronous Pulsatile Release of Luteinizing Hormone and Immunoreactive Beta‐Endorphin from the Human Pituitary in vitro

S. Yen, W. Rossmanith, D. Rasmussen, 1990, Journal of neuroendocrinology.

Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse.

J. Froehlich, Stephen M. Fischer, D. Rasmussen, 2015, Alcoholism, clinical and experimental research.

Episodic gonadotropin-releasing hormone release from the rat isolated median eminence in vitro.

D. Rasmussen, Dennis D. Rasmussen, 1993, Neuroendocrinology.

HUMAN FETAL HYPOTHALAMIC GnRH NEUROSECRETION: DOPAMINERGIC REGULATION IN VITRO

J. Liu, S. Yen, W. Swartz, 1986, Clinical endocrinology.

The α1-adrenergic receptor antagonist, doxazosin, reduces alcohol drinking in alcohol-preferring (P) Rats.

Meghan L O'Neil, D. Rasmussen, C. Kincaid, 2013, Alcoholism, clinical and experimental research.

Prazosin Prevents Increased Anxiety Behavior That Occurs in Response to Stress During Alcohol Deprivations

J. Froehlich, D. Rasmussen, C. Kincaid, 2017, Alcohol and alcoholism.

Chronic daily ethanol and withdrawal: 6. Effects on rat sympathoadrenal activity during "abstinence".

M. Raskind, C. Wilkinson, D. Rasmussen, 2006, Alcohol.

Chronic daily ethanol and withdrawal

D. Sarkar, A. Gore, James L. Roberts, 2003, Endocrine.

Endogenous opioid inhibition and facilitation of gonadotropin-releasing hormone release from the median eminence in vitro: potential role of catecholamines.

T. Nett, B. Kennedy, M. Ziegler, 1988, Endocrinology.

Physiological interactions of the basic rest - activity cycle of the brain: Pulsatile luteinizing hormone secretion as a model

D. Rasmussen, 1986, Psychoneuroendocrinology.

Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats

M. Raskind, A. Tapp, D. Rasmussen, 2007, Neuropsychopharmacology.

Daily Melatonin Administration to Middle-Aged Male Rats Suppresses Body Weight, Intraabdominal Adiposity, and Plasma Leptin and Insulin Independent of Food Intake and Total Body Fat1.

A. Matsumoto, C. Wilkinson, S. Yellon, 2000, Endocrinology.

Printed in U.S.A. Copyright © 2000 by The Endocrine Society Daily Melatonin Administration to Middle-Aged Male Rats Suppresses Body Weight, Intraabdominal Adiposity, and Plasma Leptin and Insulin Independent of Food Intake and Total Body Fat*

A. Matsumoto, C. Wilkinson, S. Yellon, 2022 .

Endogenous opioid regulation of gonadotropin-releasing hormone release from the human fetal hypothalamus in vitro.

J. Liu, S. Yen, P. Wolf, 1983, The Journal of clinical endocrinology and metabolism.

Chronic daily ethanol and withdrawal: 2. Behavioral changes during prolonged abstinence.

J. Green, D. Rasmussen, D. R. Mitton, 2001, Alcoholism, clinical and experimental research.

Diurnal modulation of rat hypothalamic gonadotropin-releasing hormone release by melatonin in vitro

D. Rasmussen, 1993, Journal of endocrinological investigation.

Positive correlation between proopiomelanocortin and tyrosine hydroxylase mRNA levels in the mediobasohypothalamus of ovariectomized rats: response to estradiol replacement and withdrawal.

J. Roberts, M. Jakubowski, D. Allen, 1992, Neuroendocrinology.

Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol.

R. Veith, P. Szot, S. S. White, 1999, Alcoholism, clinical and experimental research.

Dopamine-opioid interaction in the regulation of hypothalamic gonadotropin-releasing hormone (GnRH) secretion

D. Rasmussen, 1991 .

Alcoholism, craving, and hormones: the role of leptin, ghrelin, prolactin, and the pro-opiomelanocortin system in modulating ethanol intake.

F. Wurst, K. Junghanns, J. Kornhuber, 2007, Alcoholism, clinical and experimental research.

Gonadotropin-releasing hormone neurosecretion in the human hypothalamus: in vitro regulation by dopamine.

J. Liu, S. Yen, P. Wolf, 1986, The Journal of clinical endocrinology and metabolism.

Chronic daily ethanol and withdrawal: 3. Forebrain pro-opiomelanocortin gene expression and implications for dependence, relapse, and deprivation effect.

C. Wilkinson, D. Rasmussen, B. M. Boldt, 2002, Alcoholism, clinical and experimental research.

Suppression of hypothalamic pro‐opiomelanocortin (POMC) gene expression by daily melatonin supplementation in aging rats

A. Matsumoto, B. Marck, S. Yellon, 2003, Journal of pineal research.

High postovariectomy LH levels are not due to decreased opioid inhibition of GnRH

D. Rasmussen, 1991, Brain Research Bulletin.

Endogenous opioid regulation of gonadotropin-releasing hormone release from the human fetal hypothalamus in vitro

S. Yen, P. Wolf, James H. Liu, 1984 .

Progesterone and 20 alpha-hydroxyprogesterone stimulate the in vitro release of GnRH by the isolated mediobasal hypothalamus.

S. Yen, D. Rasmussen, 1983, Life sciences.

Neurosecretion of human hypothalamic immunoreactive beta-endorphin: in vitro regulation by dopamine.

J. Liu, S. Yen, P. Wolf, 1987, Neuroendocrinology.

Effects of prazosin, an α1-adrenergic receptor antagonist, on the seeking and intake of alcohol and sucrose in alcohol-preferring (P) rats.

J. Froehlich, C. Czachowski, D. Rasmussen, 2012, Alcoholism, clinical and experimental research.

The α2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats.

J. Froehlich, D. Rasmussen, David L Federoff, 2014, Alcohol.

Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.

J. Froehlich, D. Rasmussen, Brett J Hausauer, 2013, Alcoholism, clinical and experimental research.

Characterization of the twenty-four hour secretion patterns of adrenocorticotropin and cortisol in normal women and patients with Cushing's disease.

J. Liu, R. Kazer, D. Rasmussen, 1987, The Journal of clinical endocrinology and metabolism.

Pulsatile gonadotropin-releasing hormone release from the human mediobasal hypothalamus in vitro: opiate receptor-mediated suppression.

S. Yen, M. Gambacciani, W. Swartz, 1989, Neuroendocrinology.

GnRH stimulates ACTH and immunoreactive beta-endorphin release from the rat pituitary in vitro.

S. Yen, M. Gambacciani, D. Rasmussen, 1988, Life sciences.

Increase of beta-endorphin concentrations in the plasma and pituitary neuro-intermediate lobe of the rat on the afternoon of proestrus.

S. Yen, B. Ishizuka, M. Wilkes, 1982, Life sciences.

Combining the α1 -adrenergic receptor antagonist, prazosin, with the β-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone.

J. Froehlich, D. Rasmussen, C. Kincaid, 2014, Alcoholism, clinical and experimental research.

Human hypothalamic and pituitary neuroendocrine function during in vitro perifusion.

D. Rasmussen, 1992, Progress in brain research.

Effects of prazosin, an α1-adrenergic receptor antagonist, on the seeking and intake of alcohol and sucrose in alcohol-preferring (P) rats.

J. Froehlich, C. Czachowski, D. Rasmussen, 2012, Alcoholism, clinical and experimental research.